Business Description
![Abeona Therapeutics Inc Abeona Therapeutics Inc logo](https://static.gurufocus.com/logos/0C0000097E.png?14)
Abeona Therapeutics Inc
NAICS : 325413
SIC : 2834
ISIN : US00289Y2063
Description
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 2.69 | |||||
Equity-to-Asset | -0.12 | |||||
Debt-to-Equity | -2.61 | |||||
Debt-to-EBITDA | -0.32 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -15.77 | |||||
Beneish M-Score | -0.96 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -60.7 | |||||
3-Year EBITDA Growth Rate | 51 | |||||
3-Year EPS without NRI Growth Rate | 47.3 | |||||
3-Year FCF Growth Rate | 43.7 | |||||
3-Year Book Growth Rate | -72.4 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30.35 | |||||
9-Day RSI | 36.3 | |||||
14-Day RSI | 40.13 | |||||
6-1 Month Momentum % | -20.76 | |||||
12-1 Month Momentum % | -6.31 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.61 | |||||
Quick Ratio | 5.61 | |||||
Cash Ratio | 5.24 | |||||
Days Sales Outstanding | 365 | |||||
Days Payable | 643.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -90.4 | |||||
Shareholder Yield % | -26.56 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 54.14 | |||||
Operating Margin % | -1442.63 | |||||
Net Margin % | -2190.26 | |||||
FCF Margin % | -1161.17 | |||||
ROE % | -683.63 | |||||
ROA % | -122.93 | |||||
ROIC % | -405.19 | |||||
ROC (Joel Greenblatt) % | -847.71 | |||||
ROCE % | -144.3 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 21.75 | |||||
EV-to-EBIT | -1.77 | |||||
EV-to-EBITDA | -1.85 | |||||
EV-to-Revenue | 38.2 | |||||
EV-to-FCF | -3.29 | |||||
Earnings Yield (Greenblatt) % | -56.5 | |||||
FCF Yield % | -23.51 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Abeona Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 3.5 | ||
EPS (TTM) ($) | -3.2 | ||
Beta | -1.91 | ||
Volatility % | 82.18 | ||
14-Day RSI | 40.13 | ||
14-Day ATR ($) | 0.157395 | ||
20-Day SMA ($) | 4.404485 | ||
12-1 Month Momentum % | -6.31 | ||
52-Week Range ($) | 2.90043 - 8.8 | ||
Shares Outstanding (Mil) | 40.96 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Abeona Therapeutics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Abeona Therapeutics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Abeona Therapeutics Inc Frequently Asked Questions
What is Abeona Therapeutics Inc(LTS:0H7R)'s stock price today?
The current price of LTS:0H7R is $4.14. The 52 week high of LTS:0H7R is $8.80 and 52 week low is $2.90.
When is next earnings date of Abeona Therapeutics Inc(LTS:0H7R)?
The next earnings date of Abeona Therapeutics Inc(LTS:0H7R) is 2024-08-08 Est..
Does Abeona Therapeutics Inc(LTS:0H7R) pay dividends? If so, how much?
Abeona Therapeutics Inc(LTS:0H7R) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |